[{"address1": "21925 W. Field Parkway", "address2": "Suite 235", "city": "Deer Park", "state": "IL", "zip": "60010-7278", "country": "United States", "phone": "847 787 7361", "website": "https://www.etonpharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, and commercializing pharmaceutical products for rare diseases. The company offers INCRELEX, treatment for children who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD); ALKINDI SPRINKLE, as a replacement therapy for Adrenocortical Insufficiency (\u0093AI\u0094) in children under 17 years of age, and accurate dosing for newborns and children with AI; GALZIN, as a maintenance treatment for patients with Wilson Disease who have been initially treated with a chelating agent; PKU GOLIKE, medical formula for the dietary management of phenylketonuria (\u0093PKU\u0094); Carglumic Acid, treatment of acute and chronic hyperammonemia due to N-acetylglutamate synthase (\u0093NAGS\u0094) deficiency; Betaine Anhydrous, for the treatment of homocystinuria; Nitisinone for the treatment of tyrosinemia type 1; and Amglidia for the treatment of neonatal diabetes mellitus products. It also develops ET-600 for the treatment of central diabetes insipidus; ET-700 for the treatment of treatment of Wilson disease; ET-800; Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.", "fullTimeEmployees": 31, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sean E. Brynjelsen", "age": 52, "title": "President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 1116640, "exercisedValue": 0, "unexercisedValue": 16187572}, {"maxAge": 1, "name": "Mr. David C. Krempa", "age": 35, "title": "Chief Business Officer", "yearBorn": 1989, "fiscalYear": 2024, "totalPay": 647849, "exercisedValue": 0, "unexercisedValue": 4872540}, {"maxAge": 1, "name": "Ms. Ipek  Erdogan-Trinkaus", "age": 42, "title": "Chief Commercial Officer", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 435943, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Danka  Radosavljevic", "title": "Senior Vice President of Quality & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Grossenbach", "title": "Senior Vice President of Sales Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  Guthrie", "title": "Executive VP of Commercial Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 17.23, "open": 17.31, "dayLow": 17.0407, "dayHigh": 17.5991, "regularMarketPreviousClose": 17.23, "regularMarketOpen": 17.31, "regularMarketDayLow": 17.0407, "regularMarketDayHigh": 17.5991, "payoutRatio": 0.0, "beta": 1.229, "forwardPE": 33.09434, "volume": 77795, "regularMarketVolume": 77795, "averageVolume": 245998, "averageVolume10days": 202140, "averageDailyVolume10Day": 202140, "bid": 17.38, "ask": 17.67, "bidSize": 1, "askSize": 1, "marketCap": 470378976, "fiftyTwoWeekLow": 3.18, "fiftyTwoWeekHigh": 18.41, "priceToSalesTrailing12Months": 12.057598, "fiftyDayAverage": 14.531, "twoHundredDayAverage": 10.7811, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 477124128, "profitMargins": -0.098000005, "floatShares": 20748995, "sharesOutstanding": 26817500, "sharesShort": 402632, "sharesShortPriorMonth": 235628, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.015, "heldPercentInsiders": 0.05171, "heldPercentInstitutions": 0.48651, "shortRatio": 1.52, "shortPercentOfFloat": 0.015800001, "impliedSharesOutstanding": 27365800, "bookValue": 0.915, "priceToBook": 19.1694, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -3823000, "trailingEps": -0.15, "forwardEps": 0.53, "enterpriseToRevenue": 12.231, "enterpriseToEbitda": -431.396, "52WeekChange": 4.008721, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 17.54, "targetHighPrice": 33.0, "targetLowPrice": 24.0, "targetMeanPrice": 27.66667, "targetMedianPrice": 26.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 14936000, "totalCashPerShare": 0.557, "ebitda": -1106000, "totalDebt": 29994000, "quickRatio": 1.018, "currentRatio": 2.056, "totalRevenue": 39011000, "debtToEquity": 122.785, "revenuePerShare": 1.507, "returnOnAssets": -0.025290001, "returnOnEquity": -0.19161, "grossProfits": 23411000, "freeCashflow": -18781876, "operatingCashflow": 969000, "revenueGrowth": 0.593, "grossMargins": 0.60011, "ebitdaMargins": -0.028350001, "operatingMargins": 0.08964, "financialCurrency": "USD", "symbol": "ETON", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Eton Pharmaceuticals, Inc.", "longName": "Eton Pharmaceuticals, Inc.", "corporateActions": [], "regularMarketTime": 1746724065, "exchange": "NGM", "messageBoardId": "finmb_435353222", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "epsTrailingTwelveMonths": -0.15, "epsForward": 0.53, "epsCurrentYear": 0.46667, "priceEpsCurrentYear": 37.585445, "fiftyDayAverageChange": 3.0090008, "fiftyDayAverageChangePercent": 0.20707458, "twoHundredDayAverageChange": 6.7589006, "twoHundredDayAverageChangePercent": 0.62692124, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "regularMarketChange": 0.31000137, "regularMarketDayRange": "17.0407 - 17.5991", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 245998, "regularMarketChangePercent": 1.7991955, "regularMarketPrice": 17.54, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1542119400000, "fiftyTwoWeekLowChange": 14.360001, "fiftyTwoWeekLowChangePercent": 4.515723, "fiftyTwoWeekRange": "3.18 - 18.41", "fiftyTwoWeekHighChange": -0.86999893, "fiftyTwoWeekHighChangePercent": -0.04725687, "fiftyTwoWeekChangePercent": 400.8721, "earningsTimestamp": 1747166400, "earningsTimestampStart": 1747166400, "earningsTimestampEnd": 1747166400, "earningsCallTimestampStart": 1747168200, "earningsCallTimestampEnd": 1747168200, "isEarningsDateEstimate": false, "displayName": "Eton Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]